Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04859660 · ClinicalTrials.gov registry record · Phase 2
Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy
A Phase 2 study, sponsored by University of Arizona.
- Completed
- Registry status
- Phase 2
- Development phase
- 161
- Enrollment target
NCT04859660 is a Phase 2 study that has completed, run by University of Arizona. The registered enrollment target is 161 participants.
The verdict
NCT04859660, a Phase 2 study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 161 participants
- Enrollment target
Study Summary
The aim of this study is to determine if a one time dose of tamsulosin given pre-operatively decreases the time to void and the time to discharge after minimally invasive hysterectomy.
Interventions
- DRUG Placebo
- DRUG Tamsulosin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2021-04-16 |
| Est. Completion | 2023-06-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04859660
The ClinicalTrials.gov registry entry for NCT04859660 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04859660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04859660 about?
NCT04859660 is a clinical study titled "Pre-operative Tamsulosin and Time to Spontaneous Void After Hysterectomy". The aim of this study is to determine if a one time dose of tamsulosin given pre-operatively decreases the time to void and the time to discharge after minimally invasive hysterectomy.
What is the current status of trial NCT04859660?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 161 participants. The study started on 2021-04-16. Estimated completion is 2023-06-24.
What interventions are being tested in trial NCT04859660?
The interventions under investigation include: Placebo (DRUG), Tamsulosin (DRUG).
Who is sponsoring clinical trial NCT04859660?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.